These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24084491)

  • 41. Laboratory identification of anaerobic bacteria isolated on Clostridium difficile selective medium.
    Rodriguez C; Warszawski N; Korsak N; Taminiau B; Van Broeck J; Delmée M; Daube G
    Acta Microbiol Immunol Hung; 2016 Jun; 63(2):171-84. PubMed ID: 27352971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
    Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
    J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of Clostridium difficile bacteremia in a patient with loop ileostomy.
    Choi JL; Kim BR; Kim JE; Woo KS; Kim KH; Kim JM; Lee SE; Han JY
    Ann Lab Med; 2013 May; 33(3):200-2. PubMed ID: 23667848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Specimen Type and Processing on the Detection of
    Candel-Pérez C; Martínez-Miró S; Ros-Berruezo G; Martínez-Graciá C
    Foodborne Pathog Dis; 2019 Nov; 16(11):731-737. PubMed ID: 31225737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Interactions between intestinal microbiota and Clostridioides difficile].
    Barbut F; Couturier J
    Rev Prat; 2019 Sep; 69(7):784-791. PubMed ID: 32233325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinico-microbiological analysis of toxigenic clostridium difficile from hospitalised patients in a tertiary care hospital, Mangalore, Karnataka, India.
    Justin S; Antony B
    Indian J Med Microbiol; 2019; 37(2):186-191. PubMed ID: 31745017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiniBioReactor Arrays (MBRAs) as a Tool for Studying C. difficile Physiology in the Presence of a Complex Community.
    Auchtung JM; Robinson CD; Farrell K; Britton RA
    Methods Mol Biol; 2016; 1476():235-58. PubMed ID: 27507346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diarrhea, clostridium difficile, and intestinal inflammation in residents of a long-term care facility.
    Archbald-Pannone L; Sevilleja JE; Guerrant R
    J Am Med Dir Assoc; 2010 May; 11(4):263-7. PubMed ID: 20439046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pleiotropic roles of Clostridium difficile sin locus.
    Girinathan BP; Ou J; Dupuy B; Govind R
    PLoS Pathog; 2018 Mar; 14(3):e1006940. PubMed ID: 29529083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detecting Clostridium difficile spores from inanimate surfaces of the hospital environment: which method is best?
    Claro T; Daniels S; Humphreys H
    J Clin Microbiol; 2014 Sep; 52(9):3426-8. PubMed ID: 25009047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile.
    De La Cochetière MF; Durand T; Lalande V; Petit JC; Potel G; Beaugerie L
    Microb Ecol; 2008 Oct; 56(3):395-402. PubMed ID: 18209965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119.
    Revathi G; Fralick JA; Rolfe RD
    Anaerobe; 2011 Jun; 17(3):125-9. PubMed ID: 21664468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Characterization of Mouse Monoclonal Antibodies Specific for
    Cairns CM; van Faassen H; St Michael F; Aubry A; Henry KA; Rossotti MA; Logan SM; Hussack G; Gisch N; Hogendorf WFJ; Pedersen CM; Cox AD
    ACS Chem Biol; 2020 Apr; 15(4):1050-1058. PubMed ID: 32191024
    [No Abstract]   [Full Text] [Related]  

  • 54.
    Diaz OR; Sayer CV; Popham DL; Shen A
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950380
    [No Abstract]   [Full Text] [Related]  

  • 55. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global analysis of the sporulation pathway of Clostridium difficile.
    Fimlaid KA; Bond JP; Schutz KC; Putnam EE; Leung JM; Lawley TD; Shen A
    PLoS Genet; 2013; 9(8):e1003660. PubMed ID: 23950727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.
    Burnham CA; Carroll KC
    Clin Microbiol Rev; 2013 Jul; 26(3):604-30. PubMed ID: 23824374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics.
    Harris HC; Best EL; Normington C; Saint-Lu N; Sablier-Gallis F; de Gunzburg J; Andremont A; Wilcox MH; Chilton CH
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins.
    Putnam EE; Nock AM; Lawley TD; Shen A
    J Bacteriol; 2013 Mar; 195(6):1214-25. PubMed ID: 23292781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection.
    Knippel RJ; Zackular JP; Moore JL; Celis AI; Weiss A; Washington MK; DuBois JL; Caprioli RM; Skaar EP
    PLoS Pathog; 2018 Dec; 14(12):e1007486. PubMed ID: 30576368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.